Eric Rojas

Eric Rojas has a diverse work experience spanning over several companies and roles. Eric is currently the Vice President and Head of Investor Relations at Stoke Therapeutics since April 2021. Prior to that, they worked at Vertex Pharmaceuticals as the Senior Director of Investor Relations from May 2014 to April 2021.

Before joining Vertex Pharmaceuticals, Eric held the position of Senior Director of Investor Relations at Shire Pharmaceuticals from February 2007 to May 2014. Prior to that, they served as the Controller at Shire Human Genetic Therapies from August 2005 to January 2007.

Eric's career started at Transkaryotic Therapies Inc., where they worked as a Senior Manager of Finance Operations from September 2001 to July 2005. Eric then moved on to Rhodia ChiRex as a Controller from June 1999 to September 2001.

Prior to these roles, Eric worked as a Project Manager for Financial Systems at Serono from July 1997 to June 1999. Their professional journey began at Arthur Andersen LLP, where they served as an Audit and Business Advisory Senior from September 1993 to July 1997.

Eric Rojas attended the University of Notre Dame from 1989 to 1993, where they pursued a Bachelor of Business Administration degree with a specialization in Accounting.